Novapep
Business Services · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
L 13 234 George St, Sydney, New South Wa...Website
www.novapep.comRevenue
<$5 MillionIndustry
About Novapep
Is Novapep your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Novapep recently announced quarterly report
Funding: Get notified immidiatlly once Novapep has new funding data
Congratulate Masked Content for being promoted to Masked Content at Novapep
Click to see if Novapep had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Novapep, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Novapep has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Novapep launches new products
Check out if Novapep is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Novapep as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Novapep is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Novapep is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Novapep.
Novapep Tech Stack
A closer look at the technologies used by Novapep
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Novapep
Novapep is an Australian-US biotech company focused on developing anti-inflammatory and cytoprotective peptides, specifically analogs of its NVP-202 agonist peptide. The company aims to address unmet medical needs by mimicking the cell-signaling mechanisms of Activated Protein C (APC). With promising preclinical data, Novapep is working on modified... Read More